- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on g. Breast Cancer (Triple Negative Type)
Total 2095 results
-
Shengjing HospitalNot yet recruitingTriple Negative Breast CancerChina
-
Shanghai Henlius BiotechNot yet recruiting
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Active, not recruitingTriple Negative Breast CancerChina
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; National Institute for Health Research Biomedical...Active, not recruitingTriple Negative Breast CancerUnited Kingdom
-
AVEO Pharmaceuticals, Inc.Astellas Pharma IncTerminatedTriple Negative Breast CancerGermany, Taiwan, Spain, Ukraine, Australia, Korea, Republic of, Canada, United States, Italy, Bahamas
-
Fudan UniversityChinese Anti-Cancer AssociationCompletedTriple Negative Breast Cancer
-
Dartmouth-Hitchcock Medical CenterNot yet recruitingTriple Negative Breast Cancer | Residual Disease
-
HutchmedActive, not recruitingRectal Cancer | Advanced Solid Tumors | Metastatic Breast Cancer | Triple Negative Breast Cancer | Metastatic Colon Cancer | Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Breast Cancer FoundationRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Hormone Receptor-positive Breast CancerUnited States
-
Samsung Medical CenterRecruitingTriple Negative Breast Cancer | Immune Checkpoint InhibitorKorea, Republic of
-
National University Hospital, SingaporeMerck Sharp & Dohme LLC; Adagene IncRecruitingTriple Negative Breast Cancer | Advanced Solid TumorSingapore
-
Zhejiang Cancer HospitalSun Yat-sen University; Fujian Cancer Hospital; Hunan Cancer Hospital; Zhejiang... and other collaboratorsNot yet recruitingTriple Negative Breast Cancer | Homologous Recombination Deficiency
-
Gilead SciencesMerck Sharp & Dohme LLCRecruitingTriple Negative Breast Cancer | PD-L1 PositiveUnited States, Taiwan, Belgium, Australia, Austria, Israel, Spain, Italy, Korea, Republic of, Japan, France, Netherlands, Canada, Turkey, Germany, Malaysia, Singapore, United Kingdom, Hong Kong, Hungary, Mexico, Switzerland, Puerto... and more
-
TransThera Sciences (Nanjing), Inc.Active, not recruitingAdvanced Solid Tumors | Triple Negative Breast CancerUnited States, China
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | TN ER-/PR-/HER2- Breast Cancer | ERany/PRany/HER2+ Breast CancerUnited States
-
pharmaand GmbHGilead SciencesTerminatedOvarian Cancer | Solid Tumor | Urothelial Carcinoma | Triple-negative Breast CancerUnited States
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingMetastatic Breast CancerNetherlands
-
Fudan UniversityActive, not recruiting
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
Indonesia UniversityRecruitingTriple Negative Breast Cancer | Chemotherapy Effect | Simvastatin Adverse ReactionIndonesia
-
University of MalayaPfizer; Cancer Research Malaysia; Pantai Hospital Kuala Lumpur; Hospital Sultan...RecruitingTriple Negative Breast Cancer | HRD 100 Gene Expression HighMalaysia
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Italy, France
-
National Cancer Institute (NCI)TerminatedTriple-Negative Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Advanced Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownTriple-Negative Invasive Breast Carcinoma | Residual TumorMexico
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Syndax PharmaceuticalsTerminatedBreast Cancer | Invasive Breast Cancer | ER-Negative PR-Negative HER2-Negative Breast CancerUnited States
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Early Stage Triple-Negative Breast CarcinomaUnited States, Puerto Rico
-
Sun Yat-sen UniversityTerminatedCarcinoma Breast Stage IVChina
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, China, Italy, Australia, United Kingdom, Korea, Republic of, Vietnam, Japan, Turkey, Brazil, Taiwan, Thailand, Canada, Argentina, India, France, Singapore, Mexico, Germany, Philippines, Poland, South Africa
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Fudan UniversityActive, not recruitingTriple Negative Breast CancerChina
-
Jules Bordet InstituteAstraZenecaActive, not recruitingTriple Negative Breast CancerFrance, Belgium
-
Jiangsu HengRui Medicine Co., Ltd.CompletedTriple Negative Breast CancerChina
-
Jewish General HospitalExactis Innovation; Genome QuebecCompletedTriple Negative Breast CancerCanada, United States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.SuspendedTriple Negative Breast CancerChina
-
University of WashingtonMerck Sharp & Dohme LLCWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor NegativeUnited States
-
Institute of Cancer Research, United KingdomAstraZenecaRecruitingBreast NeoplasmUnited Kingdom
-
Shanghai Jiao Tong University School of MedicineRecruiting
-
Eisai Inc.Merck Sharp & Dohme LLCCompleted
-
University of Colorado, DenverCancer League of ColoradoWithdrawnMetastatic Breast Cancer | Triple Negative Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast Carcinoma | PD-L1 Gene MutationUnited States
-
BerGenBio ASAMerck Sharp & Dohme LLCTerminatedTriple Negative Breast Cancer | Inflammatory Breast Cancer Stage IVSpain, United States, United Kingdom, Norway
-
Fudan UniversityNot yet recruitingTNBC - Triple-Negative Breast Cancer
-
Zhejiang Cancer HospitalNot yet recruiting
-
BioNTech SENot yet recruitingTriple Negative Breast Cancer | Locally Advanced Breast Cancer
-
Ain Shams UniversityActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerEgypt
-
Gene SolutionsRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Breast Cancer Female | Stage III Breast CancerVietnam
-
European Institute of OncologyRecruitingTriple Negative Breast Cancer | HER2-positive Breast Cancer | Invasive Breast CancerItaly
-
Seoul National University HospitalTerminatedMetaplastic Breast CarcinomaKorea, Republic of
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowRecruitingMetastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Recurrent Breast Cancer | ER+ Breast CancerUnited Kingdom